XbaI GLUT1 gene polymorphism and the risk of type 2 diabetes with nephropathy

Disease Markers

Volumn 27, Issue 1, 2009, Pages 29-35

  Stefanidis, Ioannis ^a   Kytoudis, Kyriakos ^a   Papathanasiou, Afroditi A ^a   Zaragotas, Dimitrios ^a   Melistas, Lambros ^b   Kitsios, Georgios D ^a,c   Yiannakouris, Nikolaos ^b   Zintzaras, Elias ^a,c  

^a UNIVERSITY OF THESSALY   (Greece)

^b HAROKOPIO UNIVERSITY   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes type 2; Diabetic microangiopathy; Diabetic nephropathy; GLUT1; Polymorphism

Indexed keywords

GLUCOSE TRANSPORTER 1;

AGED; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; FEMALE; GENETIC ANALYSIS; GREECE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR;

EID: 70350510093     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2009-0648     Document Type: Article

References (37)

1. F. Valderrabano, F.C. Berthoux, E.H. Jones and O. Mehls, Report on management of renal failure in Europe, XXV, 1994 end stage renal disease and dialysis report. The EDTA-ERA Registry. European Dialysis and Transplant Association- European Renal Association, Nephrol Dial Transplant 11 (1996), S2-S21.
2. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med 329 (1993), 977-986.
3. E. Zintzaras, K. Uhlig, G.N. Koukoulis, A.A. Papathanasiou and I. Stefanidis, Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis, J Hum Genet 52 (2007), 881-890.
4. M. Quinn, M.C. Angelico, J.H. Warram and A.S. Krolewski, Familial factors determine the development of diabetic nephropathy in patients with IDDM, Diabetologia 39 (1996), 940-945.
5. K. Strojek, W. Grzeszczak, E. Morawin, M. Adamski, B. Lacka, H. Rudzki et al., Nephropathy of type II diabetes: evidence for hereditary factors? Kidney Int 51 (1997), 1602-1607. (Pubitemid 27239918)
6. E. Zintzaras and I. Stefanidis, Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis, J Hum Genet 50 (2005), 84-91.
7. Z.H. Liu, T.J. Guan, Z.H. Chen and L.S. Li, Glucose transporter (GLUT1) allele (XbaI) associated with nephropathy in non-insulin-dependent diabetes mellitus, Kidney Int 55 (1999), 1843-1848.
8. C. Gutierrez, J. Vendrell, R. Pastor, M. Broch, C. Aguilar, C. Llor et al., GLUT1 gene polymorphism in non-insulindependent diabetes mellitus: genetic susceptibility relationship with cardiovascular risk factors and microangiopathic complications in a Mediterranean population, Diabetes Res Clin Pract 41 (1998), 113-120.
9. W. Grzeszczak, D.K. Moczulski, M. Zychma, E. Zukowska- Szczechowska, W. Trautsolt and I. Szydlowska, Role of GLUT1 gene in susceptibility to diabetic nephropathy in type 2 diabetes, Kidney Int 59 (2001), 631-636.
10. E. Zintzaras and J. Lau, Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches, J Clin Epidemiol 61 (2008), 634-645.
11. E. Zintzaras and J. Lau, Trends in meta-analysis of genetic association studies, J Hum Genet 53 (2008), 1-9.
12. S. Genuth, K.G. Alberti, P. Bennett, J. Buse, R. Defronzo, R. Kahn et al., Follow-up report on the diagnosis of diabetes mellitus, Diabetes Care 26 (2003), 3160-3167.
13. T. Tao, Y. Tanizawa, A. Matsutani, A. Matsubara, T. Kaneko and K. Kaku, HepG2/erythrocyte glucose transporter (GLUT1) gene in NIDDM: a population association study and molecular scanning in Japanese subjects, Diabetologia 38 (1995), 942-947.
14. B.S. Weir, Genetic Data Analysis II: Methods for Discrete Population Genetic Data, Sunderland, Massachusetts: Sinausociates (1996).
15. E. Zintzaras and G.M. Hadjigeorgiou, Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis, J Hum Genet 49 (2004), 474-481.
16. C.W. Heilig, L.A. Concepcion, B.L. Riser, S.O. Freytag, M. Zhu and P. Cortes, Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype, J Clin Invest 96 (1995), 1802-1814.
17. C.W. Heilig, F.C. Brosius, III. and D.N. Henry, Glucose transporters of the glomerulus and the implications for diabetic nephropathy, Kidney Int Suppl 60 (1997), S91-S99.
18. C.W. Heilig, Y. Liu, R.L. England, S.O. Freytag, J.D. Gilbert, K.O. Heilig et al., D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells: implications for diabetic nephropathy, Diabetes 46 (1997), 1030-1039.
19. R.G. Larkins and M.E. Dunlop, The link between hyperglycaemia and diabetic nephropathy, Diabetologia 35 (1992), 499-504.
20. P. Mahadevan, R.G. Larkins, J.R. Fraser, A.J. Fosang and M.E. Dunlop, Increased hyaluronan production in the glomeruli from diabetic rats: a link between glucose-induced prostaglandin production and reduced sulphated proteoglycan, Diabetologia 38 (1995), 298-305.
21. D.N. Henry, J.V. Busik, F.C. Brosius, III. and C.W. Heilig, Glucose transporters control gene expression of aldose reductase, PKCa, and GLUT1 in mesangial cells in vitro, Am J Physiol 277 (1999), 97-104.
22. A. Mogyorosi and F.N. Ziyadeh, GLUT1 and TGF-beta: the link between hyperglycaemia and diabetic nephropathy, Nephrol Dial Transplant 14 (1999), 2827-2829.
23. R. Fernandes, A.L. Carvalho, A. Kumagai, R. Seica, K. Hosoya, T. Terasaki et al., Downregulation of retinal GLUT1 in diabetes by ubiquitinylation, Mol Vis 10 (2004), 618-628.
24. S.R. Li, M.G. Baroni, R.S. Oelbaum, J. Stock and D.J. Galton, Association of genetic variant of the glucose transporter with non-insulin-dependent diabetes mellitus, Lancet 2 (1988), 368-370.
25. M.G. Baroni, R.S. Oelbaum, P. Pozzilli, J. Stocks, S.R. Li, V. Fiore et al., Polymorphisms at the GLUT1 (HepG2) and GLUT4 (muscle/adipocyte) glucose transporter genes and non-insulin-dependent diabetes mellitus (NIDDM), Hum Genet 88 (1992), 5575-15561
26. Y. Ohkubo, H. Kishikawa, E. Araki, T. Miyata, S. Isami, S. Motoyoshi et al., Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study, Diabetes Res Clin Pract 28 (1995), 103-117.
27. L.S. Rallidis, M.G. Zolindaki, V.K. Chatziioakimidis, A.H. Velissaridou, E.S. Konstantellou and E.G. Papasteriadis, High prevalence and suboptimal treatment of risk factors in Greek coronary patients, Acta Cardiol 56 (2001), 7-15.
28. G.S. Markowitz, J. Lin, A.M. Valeri, C. Avila, S.H. Nasr and V.D. D'Agati, Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking, Hum Pathol 33 (2002), 826-835.
29. T. Kusaba, T. Hatta, K. Sonomura, Y. Mori, T. Tokoro, T. Nagata et al., Idiopathic nodular glomerulosclerosis: three Japanese cases and review of the literature, Clin Nephrol 67 (2007), 32-37.
30. T. Sanai, S. Okuda, T. Yoshimitsu, N. Oochi, H. Kumagai, R. Katafuchi et al., Nodular glomerulosclerosis in patients without any manifestation of diabetes mellitus, Nephrology (Carlton) 12 (2007), 69-73.
31. A.M. Herzenberg, J.K. Holden, S. Singh and A.B. Magil, Idiopathic nodular glomerulosclerosis, Am J Kidney Dis 34 (1999), 560-564.
32. K.G. dos Santos, L.H. Canani, J.L. Gross, B. Tschiedel, K.E. Souto and I. Roisenberg, The catalase -262C/T promoter polymorphism and diabetic complications in Caucasians with type 2 diabetes, Dis Markers 22 (2006), 355-359.
33. M.G. Petrovic, I. Cilensek and D. Petrovic, Manganese superoxide dismutase gene polymorphism (V16A) is associated with diabetic retinopathy in Slovene (Caucasians) type 2 diabetes patients, Dis Markers 24 (2008), 59-64.
34. I. Ezzidi, N. Mtiraoui, M.B. Mohamed, T. Mahjoub, M. Kacem andW.Y. Almawi, Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and 786T>C gene variants with diabetic nephropathy, J Diabetes Complications 22 (2008), 331-338.
35. D.C. Simonson, Etiology and prevalence of hypertension in diabetic patients, Diabetes Care 11 (1988), 821-827.
36. R. Perez-Fernandez, A.F. Marino, C. Cadarso-Suarez, M.A. Botana, M.A. Tome, I. Solache et al., Prevalence, awareness, treatment and control of hypertension in Galicia (Spain) and association with related diseases, J Hum Hypertens 23 (2007), 234-241.
37. A.D. Hodgkinson, B.A. Millward and A.G. Demaine, Polymorphisms of the glucose transporter (GLUT1) gene are associated with diabetic nephropathy, Kidney Int 59 (2001), 985-989.